On today's episode, we will be discussing Buspirone (Buspar), a commonly used medication for anxiety.

References:

• https://www.sciencedirect.com/science/article/pii/S2405844024049491
• https://pubmed.ncbi.nlm.nih.gov/3041384/
• https://www.ncbi.nlm.nih.gov/books/NBK531477/
• https://pubmed.ncbi.nlm.nih.gov/39493804/
• https://pubmed.ncbi.nlm.nih.gov/22998742/
  

Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu!

Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108

References:

https://psychiatryonline.org/doi/10.1176/appi.focus.18103

https://psycnet.apa.org/record/2015-37696-000

Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety.

References:

https://pubmed.ncbi.nlm.nih.gov/9616188/

https://pubmed.ncbi.nlm.nih.gov/27998379/

https://pubmed.ncbi.nlm.nih.gov/21154375/

https://pubmed.ncbi.nlm.nih.gov/1345410/

We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more!

References

- https://pubmed.ncbi.nlm.nih.gov/38273108/

- https://pubmed.ncbi.nlm.nih.gov/34113269/

- https://pubmed.ncbi.nlm.nih.gov/39296512/

- https://pmc.ncbi.nlm.nih.gov/articles/PMC12089804/

- https://pubmed.ncbi.nlm.nih.gov/40043464/

- https://pubmed.ncbi.nlm.nih.gov/28137247/

Metabolic Mind: https://www.metabolicmind.org/

Free CME: https://www.mycme.com/courses/ketogenic-therapy-treatment-for-serious-mental-illness-10028

Baszucki Group: https://baszuckigroup.com/

Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli.

References:

• https://pmc.ncbi.nlm.nih.gov/articles/PMC2899886/

• https://www.nature.com/articles/s41398-018-0118-6

• https://www.nature.com/articles/s41598-022-15489-9

• https://pmc.ncbi.nlm.nih.gov/articles/PMC5913255/

On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails.

Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract’

One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1

SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720

On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network.

References:

• https://pubmed.ncbi.nlm.nih.gov/30250390/

• https://pmc.ncbi.nlm.nih.gov/articles/PMC4162869/

• https://link.springer.com/article/10.3758/s13415-011-0083-5

• https://www.cell.com/neuron/comments/S0896-6273(06)00349-7

• https://pubmed.ncbi.nlm.nih.gov/18799601/

• https://www.nature.com/articles/s41386-021-01132-0

On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies.

Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/

Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network.

References

• https://pmc.ncbi.nlm.nih.gov/articles/PMC7959111/

• https://pubmed.ncbi.nlm.nih.gov/37167968/

• https://www.nature.com/articles/s42003-019-0611-3

• https://www.psychiatrictimes.com/view/mindwandering-mood-for-thought

• https://www.nature.com/articles/s41380-021-01403-8

• https://www.sciencedirect.com/science/article/abs/pii/S0167876022000071

• https://www.nature.com/articles/tp201740

• https://pubmed.ncbi.nlm.nih.gov/25938726/

Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).